Cargando…

Effects of a Formula with scGOS/lcFOS (9:1) and Glycomacropeptide (GMP) Supplementation on the Gut Microbiota of Very Preterm Infants

Microbial colonization of very preterm (VPT) infants is detrimentally affected by the complex interplay of physiological, dietary, medical, and environmental factors. The aim of this study was to evaluate the effects of an infant formula containing the specific prebiotic mixture of scGOS/lcFOS (9:1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xue, Xing, Yan, Liu, Hui, Chang, Yanmei, You, Yanxia, Dou, Yuqi, Liu, Bin, Wang, Qi, Ma, Defu, Chen, Lijun, Tong, Xiaomei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102166/ https://www.ncbi.nlm.nih.gov/pubmed/35565868 http://dx.doi.org/10.3390/nu14091901

Ejemplares similares

Supplementation With 2′-FL and scGOS/lcFOS Ameliorates Rotavirus-Induced Diarrhea in Suckling Rats
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2018)

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns: A Prospective Cohort Study
por: Tonon, Karina Merini, et al.
Publicado: (2021)

Dataset on the Life Cycle Assessment of fructo- and galacto-oligosaccharides (FOS and GOS) produced by synthesis or hydrolysis
por: Gerbino, Esteban, et al.
Publicado: (2022)

In Vitro Evaluation of the Effects of Commercial Prebiotic GOS and FOS Products on Human Colonic Caco–2 Cells
por: Lafontaine, Geraldine M. Flaujac, et al.
Publicado: (2020)

Chemical and functional properties of glycomacropeptide (GMP) and its role in the detection of cheese whey adulteration in milk: a review
por: Neelima, et al.
Publicado: (2013)

Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population
por: Liu, Feitong, et al.
Publicado: (2017)

Unveiling the Metabolic Effects of Glycomacropeptide
por: Pena, Maria João, et al.
Publicado: (2021)

An Evaluation of the Mechanisms of Galacto-Oligosaccharide (GOS)-Induced IgE Cross-Linking on Basophils in GOS Allergy
por: Lee, Li Yuan Gabriella Nadine, et al.
Publicado: (2022)

Distribution and Influencing Factors of the Sialic Acid Content in the Breast Milk of Preterm Mothers at Different Stages
por: Chen, Zekun, et al.
Publicado: (2022)

Effects of oral supplementation with FOS and GOS prebiotics in women with adult acne: the “S.O. Sweet” study: a proof-of-concept pilot trial
por: Dall’Oglio, Federica, et al.
Publicado: (2018)

The Use of Glycomacropeptide in Dietary Management of Phenylketonuria
por: Zaki, Osama K., et al.
Publicado: (2016)

Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial
por: Ashley, Claude, et al.
Publicado: (2012)

Determination of β-Galactooligosaccharides (GOS) in Infant Formula and Adult Nutritionals: Single-Laboratory Validation, First Action 2021.01
por: Cuany, Denis, et al.
Publicado: (2021)

A call for an international network of genomic observatories (GOs)
por: Davies, Neil, et al.
Publicado: (2012)

The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations
por: Sauvé, Mathilde Foisy, et al.
Publicado: (2021)

Glycomacropeptide in PKU—Does It Live Up to Its Potential?
por: Daly, Anne, et al.
Publicado: (2022)

Gos: a declarative library for interactive genomics visualization in Python
por: Manz, Trevor, et al.
Publicado: (2023)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021)

Influence of Glycomacropeptide on Rehydration Characteristics of Micellar Casein Concentrate Powder
por: Panthi, Ram R., et al.
Publicado: (2021)

Protective Effect of Glycomacropeptide on the Inflammatory Response of U937 Macrophages
por: Córdova-Dávalos, Laura Elena, et al.
Publicado: (2023)

Evaluation of Safety through Acute and Subacute Tests of Galacto-Oligosaccharide (GOS)
por: Baek, Youngjin, et al.
Publicado: (2021)

Some Information Measures Properties of the GOS-Concomitants from the FGM Family
por: Suter, Florentina, et al.
Publicado: (2022)

Fractionation of Glycomacropeptide from Whey Using Positively Charged Ultrafiltration Membranes
por: Arunkumar, Abhiram, et al.
Publicado: (2018)

The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pena, Maria João, et al.
Publicado: (2018)

A Preclinical Study of Casein Glycomacropeptide as a Dietary Intervention for Acute Mania
por: Liebenberg, Nico, et al.
Publicado: (2018)

Glycomacropeptide Bioactivity and Health: A Review Highlighting Action Mechanisms and Signaling Pathways
por: Córdova-Dávalos, Laura Elena, et al.
Publicado: (2019)

Analysis of Bovine Kappa-Casein Glycomacropeptide by Liquid Chromatography–Tandem Mass Spectrometry
por: Qu, Yunyao, et al.
Publicado: (2021)

Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
por: Pena, Maria João, et al.
Publicado: (2021)

Cheese Whey Milk Adulteration Determination Using Casein Glycomacropeptide as an Indicator by HPLC
por: Vera-Bravo, Ricardo, et al.
Publicado: (2022)

Semi-Online Scheduling on Two Machines with GoS Levels and Partial Information of Processing Time
por: Luo, Taibo, et al.
Publicado: (2014)

Quantification of cGMP in human plasma by isotope dilution LC-MS/MS
por: Martens-Lobenhoffer, Jens, et al.
Publicado: (2009)

Prebiotic effect during the first year of life in healthy infants fed formula containing GOS as the only prebiotic: a multicentre, randomised, double-blind and placebo-controlled trial
por: Sierra, Carlos, et al.
Publicado: (2014)

Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide Diet
por: Solverson, Patrick, et al.
Publicado: (2012)

Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
por: Pinto, A., et al.
Publicado: (2017)

Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial(1)(2)
por: Ney, Denise M, et al.
Publicado: (2016)

Glycomacropeptide Ameliorates Indomethacin-Induced Enteropathy in Rats by Modifying Intestinal Inflammation and Oxidative Stress
por: Cervantes-García, Daniel, et al.
Publicado: (2020)

Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study
por: Montanari, Chiara, et al.
Publicado: (2022)

Dynamic Changes of the Gut Microbiota in Preterm Infants With Different Gestational Age
por: Jia, Qiong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d5esctp9ps0979qit90ucdlovn